NSTI BioNano 2010

Curapel Ltd

Location:Manchester, UK
Speaker:Stephen France
Title:Venture manager
Primary Industry:Biotech & Medical
Executive Summary:Curapel is an award winning specialist healthcare company committed to the development of innovative and safe therapies for skin conditions. Curapel pipeline of therapies are aligned to patient need and are positioned to restore the skins barrier function and break the “scratch itch” cycle that feeds skin diseases. Lead oral Nutraceutical formulations have significant growth potential and have advanced through successful clinical evaluation studies in Atopic dermatitis (Eczema). Placebo control clinical studies have demonstrated a 40% improvement in atopic dermatitis disease over a 30 day period. Topical formulations are currently in clinical evaluation and pediatric formulation are in late stage pre clinical development. With multiple formulations and disease applications Curapel's lead therapy represents a pipeline in a treatment. For each disease application a ranges of commercial co-development and out licensing partnerships are anticipated and discussions are underway with a number of companies in this respect.
Venture is:Seed Level

 
Program | Symposia | Speaker Exhibitor | Press Venue Registration |
Short Courses | News | Subscribe | Contact | Site Map
© Copyright 2009 TechConnect World. All Rights Reserved.